The FDA has granted priority review to the new drug application (NDA) for gedatolisib, a first-in-class multi-target ...

A new study reveals a critical vulnerability in a brain receptor targeted by a rare autoimmune disease. Researchers have ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...

Awardees will receive $330,000 grants co-funded by Yosemite and the American Cancer Society to pursue critical cancer ...

Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...

Urinary system tumors are a group of tumors that occur in the kidney, ureter, bladder and urethra, of which bladder cancer is the most common, followed by ...

Ianalumab targets the BAFF receptor, depleting malignant B cells and enhancing ibrutinib's efficacy, offering a potential ...

Discover the innovative Alco5 platform by Tubulis, advancing cancer therapies with novel antibody-drug conjugate technology.

Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, ...